| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Josep Dalmau | Q37828790 |
| P2093 | author name string | Ankit Jain | |
| Rita J Balice-Gordon | |||
| Xiaoyu Peng | |||
| Emilia H Moscato | |||
| Ethan G Hughes | |||
| P2860 | cites work | Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia | Q22241679 |
| Guillain-Barré syndrome | Q24276200 | ||
| Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis | Q24620536 | ||
| Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies | Q24642126 | ||
| Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents | Q24644532 | ||
| IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis | Q24648462 | ||
| Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma | Q24653500 | ||
| New players tip the scales in the balance between excitatory and inhibitory synapses | Q24796169 | ||
| A patient with encephalitis associated with NMDA receptor antibodies | Q27480951 | ||
| Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis | Q27490347 | ||
| Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core | Q27628494 | ||
| X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor | Q27658372 | ||
| Potassium channel antibodies in two patients with reversible limbic encephalitis | Q28206692 | ||
| Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region | Q28218836 | ||
| Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis | Q28244864 | ||
| Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis | Q28245345 | ||
| Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice | Q28259705 | ||
| Activity-dependent scaling of quantal amplitude in neocortical neurons | Q28264163 | ||
| B-cell depletion with rituximab in relapsing-remitting multiple sclerosis | Q28268626 | ||
| The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory | Q28300376 | ||
| Inducible and reversible NR1 knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain | Q28510326 | ||
| Mice with reduced NMDA receptor expression display behaviors related to schizophrenia | Q28510751 | ||
| Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies | Q37559509 | ||
| Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones | Q37690986 | ||
| Beyond viruses: clinical profiles and etiologies associated with encephalitis | Q37860911 | ||
| Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. | Q38308644 | ||
| Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). | Q39576197 | ||
| Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis | Q39961545 | ||
| Characterization of ganglionic acetylcholine receptor autoantibodies | Q39981430 | ||
| The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels | Q40733834 | ||
| Characterization of glutamate binding sites in receptors assembled from transfected NMDA receptor subunits. | Q41180674 | ||
| Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation | Q41338464 | ||
| Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction | Q41559275 | ||
| Association between Campylobacter infection and Guillain-Barré syndrome | Q41660351 | ||
| Anti‐GM1 IgG antibodies and campylobacter bacteria in Guillain‐Barré syndrome: Evidence of molecular mimicry | Q42277583 | ||
| Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis | Q42581479 | ||
| Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors | Q42628411 | ||
| Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. | Q42972398 | ||
| Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit | Q43218065 | ||
| Effect of LPS on the permeability of the blood-brain barrier to insulin | Q43558962 | ||
| Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice | Q43646279 | ||
| A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus | Q43786936 | ||
| Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations | Q43866400 | ||
| Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia | Q44045578 | ||
| Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia | Q44069097 | ||
| Spatial memory dissociations in mice lacking GluR1. | Q44114033 | ||
| Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress | Q44220866 | ||
| Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia | Q37306496 | ||
| Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity | Q37315963 | ||
| Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function | Q37361552 | ||
| Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss. | Q37387340 | ||
| Autoimmune disorders of the neuromuscular junction | Q37475932 | ||
| A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin | Q37535578 | ||
| Developmental and regional expression in the rat brain and functional properties of four NMDA receptors | Q28570615 | ||
| Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor | Q28588523 | ||
| Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit | Q28592875 | ||
| The cell biology of synaptic plasticity: AMPA receptor trafficking | Q29615771 | ||
| Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 | ||
| Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. | Q30484724 | ||
| Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus | Q30485404 | ||
| Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome | Q30827235 | ||
| Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody | Q30920813 | ||
| Limbic encephalitis and variants: classification, diagnosis and treatment. | Q31127230 | ||
| Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. | Q31940595 | ||
| Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease | Q33375581 | ||
| Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes | Q33556077 | ||
| Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. | Q33666104 | ||
| A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica | Q33727402 | ||
| Developmental seizure susceptibility of kv1.1 potassium channel knockout mice | Q33781005 | ||
| NMDA receptor hypofunction model of schizophrenia | Q33813143 | ||
| Lambert-Eaton myasthenic syndrome as an autoimmune calcium-channelopathy | Q33843210 | ||
| Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis | Q33865528 | ||
| Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients | Q33907001 | ||
| Apheresis treatment in Lambert-Eaton myasthenic syndrome | Q33916821 | ||
| Paraneoplastic syndromes of the nervous system | Q33931301 | ||
| Passive transfer of autoimmune autonomic neuropathy to mice | Q33938477 | ||
| Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni | Q33938778 | ||
| Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound | Q33992793 | ||
| Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1). | Q33997506 | ||
| Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis | Q34058599 | ||
| Effects of ketamine in normal and schizophrenic volunteers | Q34091266 | ||
| Paraneoplastic syndromes of the spinal cord, nerve, and muscle | Q34096509 | ||
| NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia | Q34149624 | ||
| Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. | Q34207767 | ||
| Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. | Q34233629 | ||
| Immunity and behavior: antibodies alter emotion | Q34270963 | ||
| Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves | Q34289244 | ||
| Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption | Q44991153 | ||
| Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia. | Q45935762 | ||
| Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy | Q46052051 | ||
| Reduced N-acetylaspartate in the basal ganglia of a patient with anti-NMDA receptor encephalitis | Q46122239 | ||
| The genetics of schizophrenia converge upon the NMDA glutamate receptor. | Q46149556 | ||
| Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. | Q46267461 | ||
| Development of human visual cortex: a balance between excitatory and inhibitory plasticity mechanisms | Q46385324 | ||
| Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia | Q46473954 | ||
| Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia | Q46505377 | ||
| Paraneoplastic encephalitis associated with ovarian teratoma and N-methyl-D-aspartate receptor antibodies | Q46879776 | ||
| Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample | Q46982053 | ||
| Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes | Q47951852 | ||
| Effects of Mothers' Autoimmune Disease During Pregnancy on Learning Disabilities and Hand Preference in Their Children | Q47974068 | ||
| Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis | Q48111449 | ||
| Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning | Q48189640 | ||
| Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. | Q48242571 | ||
| Multiple behavioral anomalies in GluR2 mutant mice exhibiting enhanced LTP. | Q48385892 | ||
| Altered NMDA receptor expression and behavior following postnatal hypoxia: potential relevance to schizophrenia. | Q48391660 | ||
| Deletion of glutamate receptor-A (GluR-A) AMPA receptor subunits impairs one-trial spatial memory | Q48395493 | ||
| Ongoing epileptiform activity in the post-ischemic hippocampus is associated with a permanent shift of the excitatory-inhibitory synaptic balance in CA3 pyramidal neurons. | Q48484041 | ||
| The influence of systemic lupus erythematosus on fetal development: cognitive, behavioral, and health trends. | Q48665652 | ||
| Enhanced LTP in mice deficient in the AMPA receptor GluR2. | Q48875091 | ||
| Zinc has opposite effects on NMDA and non-NMDA receptors expressed in Xenopus oocytes | Q48987834 | ||
| Paraneoplastic limbic encephalitis in a teenage girl with an immature ovarian teratoma | Q49029091 | ||
| Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. | Q51421065 | ||
| Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. | Q51957611 | ||
| Model psychoses and schizophrenia | Q52139726 | ||
| Campylobacter jejuni infection and Guillain-Barré syndrome. | Q55063212 | ||
| The Epidemiology of Myasthenia Gravis | Q56883623 | ||
| Lambert-eaton myasthenic syndrome | Q64043897 | ||
| Myasthenia Gravis: Passive Transfer from Man to Mouse | Q67318954 | ||
| Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate Degradation | Q67320379 | ||
| Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis | Q67700665 | ||
| Calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome | Q69375662 | ||
| Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma | Q70106954 | ||
| Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse | Q71147638 | ||
| Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis | Q71188155 | ||
| Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen | Q71851780 | ||
| Acetylcholine release in myasthenia gravis: regulation at single end-plate level | Q72249450 | ||
| Knockdown of AMPA receptor GluR2 expression causes delayed neurodegeneration and increases damage by sublethal ischemia in hippocampal CA1 and CA3 neurons | Q73107263 | ||
| Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seropositive patients with myasthenia gravis | Q73433373 | ||
| Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an 'adult' acetylcholine receptor subunit | Q73857348 | ||
| Sydenham's chorea | Q74093237 | ||
| Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies | Q74339283 | ||
| Guillain-Barré syndrome | Q77326744 | ||
| [Three patients with a paraneoplastic neurological syndrome: the significance of paraneoplastic antibodies] | Q80245793 | ||
| A relative weak leg muscle in the rolling Nagoya mouse as a model for Lambert-Eaton myasthenic syndrome | Q81695894 | ||
| Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain | Q34306593 | ||
| NMDA receptors, place cells and hippocampal spatial memory | Q34315328 | ||
| Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea | Q34491027 | ||
| Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations | Q34513708 | ||
| Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia | Q34529602 | ||
| Maternal neuronal antibodies associated with autism and a language disorder | Q34532394 | ||
| Antibody-mediated neuronal cell signaling in behavior and movement disorders | Q34552211 | ||
| NMDA receptor subunits: function and pharmacology. | Q34579640 | ||
| Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism | Q34588189 | ||
| Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody | Q34598388 | ||
| AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. | Q34972785 | ||
| Expanding spectrum of encephalitis with NMDA receptor antibodies in young children | Q35008179 | ||
| Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. | Q35225108 | ||
| NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia | Q35684752 | ||
| The Guillain-Barré syndrome: a true case of molecular mimicry | Q35753097 | ||
| The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors | Q35858251 | ||
| Amino terminal domain regulation of NMDA receptor function | Q35908506 | ||
| Excitatory-inhibitory balance and critical period plasticity in developing visual cortex | Q35974463 | ||
| N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease | Q35999737 | ||
| Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. | Q36002319 | ||
| Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. | Q36143265 | ||
| Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. | Q36174877 | ||
| Role of AMPA receptors in synaptic plasticity | Q36560422 | ||
| Paraneoplastic syndromes of the CNS. | Q36631871 | ||
| Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine | Q36690878 | ||
| Epilepsy, E/I Balance and GABA(A) Receptor Plasticity. | Q36852883 | ||
| Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? | Q36860053 | ||
| Detection of Pneumocystis carinii with DNA-binding bisBenzimide 33258 Hoechst | Q36895810 | ||
| Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site | Q36954416 | ||
| Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. | Q36982702 | ||
| Paraneoplastic neurological syndromes: diagnosis and treatment | Q36997070 | ||
| Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current | Q37041978 | ||
| Phencyclidine, NMDA receptor and schizophrenia | Q37102007 | ||
| Thymoma, myasthenia gravis, and other paraneoplastic syndromes | Q37177981 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | encephalitis | Q199615 |
| P304 | page(s) | 298-309 | |
| P577 | publication date | 2010-07-14 | |
| P1433 | published in | European Journal of Neuroscience | Q5412733 |
| P1476 | title | Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies | |
| P478 | volume | 32 |
| Q55254849 | A case report: anti-NMDA receptor encephalitis. |
| Q33574044 | Absence of NMDA receptor antibodies in patients with ovarian teratoma without encephalitis |
| Q38736605 | Anti-GAPDH Autoantibodies as a Pathogenic Determinant and Potential Biomarker of Neuropsychiatric Diseases |
| Q92324434 | Anti-NMDA Receptor Encephalitis Presenting with Status Epilepticus: Brucellosis as a Possible Triggering Factor: A Case Report |
| Q34661274 | Anti-NMDA Receptor Encephalitis in Psychiatry |
| Q44533955 | Anti-NR1 antibodies in anti-N-methyl-D-aspartate receptor encephalitis and schizophrenia |
| Q34036378 | Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma |
| Q90312411 | Autoantibodies in Neuropsychiatric Disorders |
| Q39128891 | Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis. |
| Q30389491 | Autoimmune encephalopathies |
| Q91577084 | Autoimmune epilepsy: findings on MRI and FDG-PET |
| Q35194421 | Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies |
| Q35903495 | Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology |
| Q24614608 | Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis |
| Q39469082 | Cognitive and Social Functioning Deficits after Anti-N-Methyl-D-Aspartate Receptor Encephalitis: An Exploratory Case Series |
| Q48166222 | Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis |
| Q47139247 | Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients. |
| Q38212790 | Epilepsy-related psychosis: a role for autoimmunity? |
| Q47108899 | Gamma-aminobutyric acid-B limbic encephalitis and asystolic cardiac arrest: a case report |
| Q48301383 | Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis. |
| Q90264151 | Limbic Encephalitis in Patients with Epilepsy-is Quantitative MRI Diagnostic? |
| Q46969402 | Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. |
| Q33740580 | Mechanisms of Autoantibody-Induced Pathology. |
| Q26801883 | Molecular Pathogenesis of Anti-NMDAR Encephalitis |
| Q57255961 | Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis/New serological markers for the differential diagnosis of autoimmune limbic encephalitis |
| Q91811291 | Neuronal NMDAR Currents of the Hippocampus and Learning Performance in Autoimmune Anti-NMDAR Encephalitis and Involvement of TNF-α and IL-6 |
| Q91973491 | Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis |
| Q51729354 | New-Onset Headache in Patients With Autoimmune Encephalitis Is Associated With anti-NMDA-Receptor Antibodies. |
| Q36812520 | Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system |
| Q35646721 | Paraneoplastic disorders |
| Q47150208 | Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Review with Pooled Analysis and Critical Care Emphasis |
| Q28303840 | Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis |
| Q28581987 | Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses |
| Q34323034 | Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications |
| Q26769676 | The Diagnosis and Treatment of Autoimmune Encephalitis |
| Q38019991 | The diagnosis and treatment of limbic encephalitis. |
| Q34913499 | The emerging link between autoimmune disorders and neuropsychiatric disease |
| Q35441181 | The growing spectrum of antibody-associated inflammatory brain diseases in children |
| Q36328761 | The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms |
| Q89262512 | [Clinical analysis of anti-NMDA receptor encephalitis complicated by paroxysmal sympathetic hyperactivity] |
Search more.